Document:

Consulting Agreement

 Exhibit 10.2 
 CONSULTING AGREEMENT 
 This
Agreement (“Agreement”) entered into the 14th day of January, 2010, and effective as of the 1st day of September 2009 (the “Effective Date”), between Biomet Inc., having its principal offices at 56 East
Bell Drive, Warsaw, Indiana 46582 (“Biomet”), and Dane A. Miller, Ph.D., having his mailing address at 16 Stone Camp, Winona Lake, Indiana 46590 (“Consultant”). 
 WITNESSETH: 
 WHEREAS, Consultant is a sole
proprietor who was formerly employed as the President and Chief Executive Officer of Biomet, and currently serves as a director of Biomet; and 
 WHEREAS, Biomet agrees to retain Consultant to provide certain consulting services to Biomet and Consultant agrees to provide such services to Biomet on the terms and conditions set forth below.

 NOW, THEREFORE, in consideration of the mutual covenants contained in the Agreement, the parties hereby agree
as follows: 
 1.    Independent Services. Biomet hereby engages Consultant to
perform certain consulting services for Biomet, its subsidiaries and affiliates, and Consultant hereby agrees to perform such services, upon the terms and conditions of this Agreement. 
 2.    Duties and Responsibilities of Consultant. During the term of this Agreement,
Consultant’s duties as a consultant for Biomet shall be: 
  

	 	 (i)
	 Tasks reasonably and customarily fulfilled by a consultant of the type and nature of Consultant, said tasks to be performed during regular business
hours of Biomet during Biomet’s customary work week, Monday through Friday, with Biomet providing Consultant reasonable notice of the tasks which Biomet will request Consultant to perform (reasonable notice by Biomet to Consultant shall not be
less than fifteen (15) days written notice by Biomet to Consultant of the tasks Consultant shall perform for and on behalf of Biomet in his capacity as a consultant to Biomet), which said tasks shall be issued from the office of Biomet’s
Chief Executive Officer; and 

  

	 	 (ii)
	 The foregoing consulting duties of Consultant shall not exceed twenty (20) hours per week, an aggregate of not greater than forty
(40) hours per month, and an aggregate of not greater than four hundred (400) hours per year; 

 3.    Compensation / Travel Expenses / W-9 Tax
Form. 
  

	 	 (a)
	 As full compensation for all authorized services rendered by Consultant under Section 2 and for any other obligations under this Agreement,
Biomet shall pay Consultant as follows: 

  

	 	 (i)
	 Biomet shall reimburse Consultant for the out-of-pocket fees and expenses of the services of a secretary and the provision of an office (not in
Biomet’s facilities), not to exceed One Hundred Thousand Dollars ($100,000), paid quarterly, per fiscal year (pro-rated for any partial years); and 

  

	 	 (ii)
	 For the consulting services identified in this Agreement, Biomet shall pay Consultant Two Hundred Fifty Thousand Dollars ($250,000), paid quarterly,
per fiscal year (pro-rated for partial years). 

  

	 	 (b)
	 Biomet agrees to provide Consultant and his spouse with coverage under the Company’s health care plans in which Consultant is entitled to
participate as an outside director of the Company or equivalent coverage until Consultant and Consultant’s spouse turn age 65. 

  

	 	 (c)
	 Biomet agrees to pay Consultant’s reasonable actual travel and lodging expenses related to travel approved in advance by the President and
Chief Executive Officer of Biomet and required for Consultant to perform the consulting services identified in this Agreement. Payment of such expenses shall be made only in the event that Consultant makes such travel and lodging arrangements
through Biomet’s travel department or a Biomet-approved travel agency. Consultant agrees that all travel and lodging expenses shall be governed by and subject to Biomet’s travel policies as made and known to Consultant from time to time.
Biomet also agrees to reimburse Consultant for minor, miscellaneous, reasonable out-of-pocket expenses related to such approved travel, such as ground transportation and modest meals, subject to receipt of reimbursement requests by Biomet and review
and approval of such expenses by Biomet. Consultant shall not bill Biomet in advance of incurring any expenses. 

  

	 	 (d)
	 In no event shall Biomet make any payment to Consultant until Consultant completes and returns a Form W-9 titled “Request for Taxpayer
Identification Number”, a copy of which form is attached hereto. 

 4.    Independent Contractor. Consultant is solely an independent contractor and agrees that neither Consultant nor Consultant’s staff are employees of Biomet, and they are not entitled to employment benefits
from Biomet with the exception of benefits as specifically set forth in Section 3. Consultant further agrees that the only monetary or economic obligation of Biomet to Consultant shall be to provide payment as set forth in Section 3.

 5.    Tax Liabilities. All amounts payable hereunder to Consultant shall be paid
without reduction by Biomet for any local, state or federal income, employment or withholding taxes, it

  

 2 

 
being the intention of the parties that Consultant shall be solely responsible for the payment of all taxes imposed or related to his business activities. 
 6.    Term and Termination. 
  

	 	 (a)
	 The term of this Agreement shall commence on the Effective Date and shall continue until the earlier of (i) the second anniversary of the
Effective Date, (ii) an Initial Public Offering, or (iii) a Change of Control (the “Term”).

  

	 	 (b)
	 Except as set forth above, either party may terminate this Agreement before the end of the Term only if the other party has breached a material term
of the Agreement, and the breaching party has failed to remedy such breach within thirty (30) calendar days following written notice from the non-breaching party. Upon such termination, Biomet shall pay to Consultant all compensation payable to
Consultant for services rendered up to the date of termination, and Biomet shall have no further liability to Consultant. 

  

	 	 (c)
	 This Agreement shall terminate immediately upon the death or disability of Consultant during the Term and in such event, Biomet shall pay to
Consultant or Consultant’s personal representative all compensation payable to Consultant for services rendered up to the date on which his death or disability occurs, and Biomet shall have no further liability to Consultant or his personal
representative. 

  

	 	 (d)
	 For purposes of this Section 6, the terms “Initial Public Offering” and “Change of Control” have the meanings
ascribed to such terms in the LVB Acquisition, Inc. Management Equity Incentive Plan, adopted November 16, 2007. 

 7.    Confidential Information. Consultant recognizes that, because of the nature of Biomet’s business and the nature of the services he will be providing to Biomet,
Consultant will, during the term of this Agreement, become acquainted with Biomet’s customers, products and technology and will be given access to such information and to certain other valuable proprietary information of a confidential nature
which is developed, compiled, and utilized by Biomet in its business. Consultant shall not, during the term of this Agreement or thereafter, disclose any item of Confidential Information of Biomet to any third party or use any such item for his own
benefit or for the benefit of any third party without the prior written consent of Biomet, until such time that such Confidential Information shall have properly become known to the general public. For purposes of this Agreement, the term
“Confidential Information,” shall mean and refer to, without limitation, (a) any information, documentation or technology designated as confidential or secret, or of any trade secret of a confidential nature which is required to be
maintained as such for continued success of the business of Biomet, or (b) any information identifying the customers to whom Biomet sells its products and services, including product and service requirements and preferences of such customers.

  

 3 

 8.    Non-Competition and Non-Solicitation.

  

	 	 (a)
	 Non-Competition. Consultant agrees that during the term of this Agreement and for one year thereafter, Consultant shall not, directly or
indirectly, engage, participate, or assist in any business organization whose activities or products are directly competitive with the activities or products of Biomet, or any subsidiary or affiliate of Biomet, in areas where the Biomet does
business, whether as owner, part-owner, stockholder, partner, director, officer, trustee, Consultant, agent, consultant or any other capacity, on his own behalf or on behalf of any corporation, partnership, or other business organization. Consultant
may make passive investments in a competitive enterprise the shares of which are publicly traded, provided that Consultant’s holdings in such enterprise, together with the holdings of any of the Consultant’s affiliates (as that term is
defined in Rule 405 of the Rules under the Securities Exchange Act of 1934, as amended), do not exceed 1% of the outstanding shares of the stock of such enterprise. 

  

	 	 (b)
	 Non-Solicitation. Consultant agrees that during the term of this Agreement and for one year thereafter, he shall not (i) directly or
indirectly solicit any person (natural or otherwise) to purchase or sell products directly or indirectly competitive with the Biomet’s products if the person is or had been a vendor or purchaser of Biomet products during the 12 months prior to
the termination of this Agreement, or (ii) recruit or otherwise solicit or induce any person who is at the time an executive, employee, consultant or sales associate of Biomet to terminate his employment with, or cease his relationship with
Biomet, or hire any such executive, consultant, or sales associate who has left the employ of the Biomet within one year of that executive’s, consultant’s, or sales associate’s employment with Biomet. 

  

	 	 (c)
	 Restrictions Reasonable. The confidentiality restrictions and the restrictions against competition and solicitation set forth above are
considered by the parties to be reasonable for the purposes of protecting the business of Biomet. If any restriction is found by a court of competent jurisdiction to be unenforceable because it extends for too long a period of time, over too broad a
range of activities or in too large a geographic area, that restriction shall be interpreted to extend only over the maximum period of time, range of activities or geographic areas as to which it may be enforceable. 

 9.    Inventions, Developments and Proprietary Rights. 
  

	 	 (a)
	 Ownership of Inventions and Developments. Consultant agrees that all Inventions and Developments which he conceives or develops, in whole or
in part, either alone or jointly with others, during the term of this Agreement with the Company will be the sole property of Biomet. Biomet will be the sole owner of all patents, copyrights and other proprietary rights in and with respect to such
Inventions and Developments. To the fullest extent permitted by law, such Inventions and Development shall be classed as “work made for hire.”

  

 4 

	 	 
Consultant hereby transfers and assigns to Biomet all proprietary rights which he may have or acquire in any Inventions and Developments, and waives all moral rights or other special rights which
he may have or which may accrue in the Inventions and Developments. The provisions of this Section 9 shall apply to all Inventions and Developments conceived or developed during the term of this Agreement with Biomet, and whether or not further
development or reduction to practice takes place after termination of this Agreement. For purposes of this Agreement, it will be presumed that the Inventions and Developments conceived by Consultant which are reduced to practice within one year
after termination of this Agreement were conceived during the term of this Agreement with Biomet, unless the Consultant is able to establish a later conception date by clear and convincing evidence. Consultant agrees to promptly disclose to Biomet
all Inventions and Developments which are or may be subject to this Agreement which represent Inventions under Section 9. 

  

	 	 (b)
	 Obtaining and Enforcing Proprietary Rights. Consultant agrees to assist Biomet, at Biomet’s request and expense, in obtaining and
enforcing patents, copyrights, and other proprietary rights with respect to Inventions and Developments throughout the world. After termination of this Agreement, Biomet shall compensate Consultant at the rate of Five Hundred Dollars ($500) per hour
for time spent by Consultant at Biomet’s request on such assistance. If Biomet is unable for any reason to secure Consultant’s signature on any document reasonably necessary or appropriate to obtain or enforce any patent, copyright and
other proprietary rights (including renewal, extensions, continuations, division or continuations in part), Consultant irrevocably designates and appoints Biomet and its duly authorized officers and agents as his agents and attorney-in-fact for the
sole purpose of executing and filing documents and doing all other lawful acts necessary to accomplish the purposes set out in this Section 9 with the same legal force and effect as if executed by Consultant. 

  

	 	 (c)
	 Definitions. For purposes of this Section 9, the following definitions apply: 

  

	 	 (i)
	 Inventions and Developments. The term “Inventions and Developments” means all inventions, developments, creative works and useful
ideas of any description (including, but not limited to, discoveries and improvements that consist of or relate to any form or Proprietary Information), whether or not patentable, which either (a) relate at the time of conception or development
to the actual or demonstrably anticipated business of Biomet or to actual or demonstrably anticipated research and development; (b) result from or relate to work performed for Biomet, whether during normal business hours or not; (c) are
developed on Consultant’s consulting time; or (d) are developed through the use of Biomet’s Proprietary Information, equipment, software or other facilities or resources. 

  

 5 

	 	 (ii)
	 Proprietary Information. The term “Proprietary Information” means information which Biomet possesses or to which Biomet has rights,
which has commercial value including, but not limited to, trade secrets, product ideas designs, configurations, processes techniques, formulas, software, improvements, invention, data, know-how, copyrightable material, marketing plans and
strategies, sales and financial reports and forecasts and customer lists. Proprietary Information includes information developed by Consultant during the term of this Agreement or otherwise relating to Inventions and Developments which belong to
Biomet under this Section 9, as well as other information to which Consultant may have access in connection with his consulting duties. 

 10 .    Governing Law. In the event of any dispute hereunder, the laws of the State of Indiana shall govern the validity, performance, enforcement and any
other aspect of this Agreement, notwithstanding any jurisdiction’s choice of law rules to the contrary. 
 11.    Arbitration. If any matter involving claims and/or disputes or other questions arising out of, or relating to this Agreement or to a breach hereto or default hereunder cannot be settled by mutual agreement
within thirty (30) days following notice by one party to the other that such party deems a claim, dispute, question, reach or default to have arisen hereunder, such matter shall be settled by arbitration in accordance with the then current CPR
Non-Administered Arbitration Rules, by a sole arbitrator. The arbitration shall be governed by the United States Arbitration Act, 9 U.S.C. §§1-16, and judgment upon the award rendered by the arbitrator may be entered by any court having
jurisdiction thereof. The place of arbitration shall be South Bend, Indiana. The arbitrator is not empowered to award punitive damages or damages in excess of compensatory damages and each party hereby irrevocably waives any right to recover any
damages other than compensatory damages with respect to any dispute resolved by arbitration. 
 12.    Federal Anti-Kickback Statute. Biomet and Consultant will not violate 42 U.S.C. § 1320 a -7b (b) (Anti-Kickback Statute) in the performance of this Agreement. 
 13.    Compliance with Laws/FCPA. In addition to the specific provisions elsewhere in this
Agreement, Consultant shall comply with all laws applicable to the services in any jurisdiction in which Consultant performs any of the services. Consultant further acknowledges that he is aware of and shall comply with the provisions of the Foreign
Corrupt Practices Act, 15 USC §78dd-1 thru 3, as amended, and any laws of any jurisdiction relating to commercial bribery. By way of example and not limitation, except as permitted by law, Consultant shall not offer, pay, or promise to pay, any
money or thing of value, directly or indirectly, to any person who is a government official for the purpose of obtaining or retaining any business. For these purposes “government official” shall include any employee of any governmental
entity, political party, or public international organization, any political party official, or any candidate for public office in any jurisdiction. 
 14.    Use of Name and Logo. Consultant will not use for publicity, promotion, or otherwise, any logo, name, trade name, service mark, or trademark of Biomet or its affiliates,
or

  

 6 

 
any simulation, abbreviation, or adaptation of the same, without Biomet’s prior, written, express consent. Biomet may withhold such consent in Biomet’s absolute discretion. 

15.    Notices. Notices required or permitted to be given under this Agreement shall be in
writing and effective upon delivery in person or by certified mail, return receipt requested, or via telefax to the parties at the addresses set forth above. 
 16.    Assignment. This Agreement and all of Consultant’s rights, duties and obligations under this Agreement are personal in nature and shall not be
assignable by Consultant. 
 17.    Non-Waiver. The failure of either party to insist
in any one or more instances upon performances of any of the provisions of this Agreement or to pursue their rights hereunder shall not be construed as a waiver of any such provision or the relinquishment of any such rights. 
 18.    Entire Agreement; Severability. This Agreement constitutes the entire understanding of the
parties and supersedes all prior discussions, negotiations, agreements and understandings, whether oral or written, with respect to its subject matter. This Agreement may be modified only by a written instrument properly executed by the both
parties. 
 The parties have executed this Agreement effective as of the day and year first above written.

  

									
	 BIOMET, INC.
	 		 	 CONSULTANT

					
	 By:
	 	 /s/ Jeffrey R. Binder
	 		 		 	 /s/ Dane A Miller

		 	 Jeffrey R. Binder
	 		 		 	 Dane A. Miller, Ph.D.

		 	 President and Chief Executive Officer
	 		 		 	 Consultant

  

 7 

 

 
  

 82005 Employee Stock Purchase Plan

 EXHIBIT 10.6 
 AEP INDUSTRIES INC. 
 2005 EMPLOYEE STOCK PURCHASE
PLAN, 
 AS AMENDED 
 (Effective December 29, 2009) 
 1.    Purpose.
The purpose of the AEP Industries Inc. 2005 Employee Stock Purchase Plan is to enable and encourage employees of the Company and its Subsidiaries to acquire the Company’s Common Stock at discounted prices, through payroll deductions, and
without payment of brokerage costs. By means of the Plan, the Company seeks to retain the services of its employees, secure and retain the services of new employees and provide incentives for its employees to perform. Further, the Company believes
that the Plan offers a convenient means for its employees who might not otherwise own Common Stock to purchase and hold such shares and further aligns such employees with the Company’s stockholders. It is the intention of the Company that the
Plan qualify as an “Employee Stock Purchase Plan” under Section 423 of the Code, and the Plan shall be administered in accordance with this intent. 
 2.    Definitions. 
 2.1    “Board of Directors” shall mean the Board of Directors of the Company. 
 2.2    “Code” shall mean the Internal Revenue Code of 1986 and any successor statute thereto, as amended. 
 2.3    “Committee” shall mean the Compensation Committee of the Board of Directors. 
 2.4    “Common Stock” shall mean shares of the Company’s common stock, $.01 par value.

 2.5    “Company” shall mean AEP Industries Inc., a Delaware corporation.

 2.6    “Compensation” as used during any calendar year with respect to an
Employee shall mean the amount of salary and hourly wages (including bonuses, overtime, commissions, sick pay, and other supplemental compensation) received by such Employee from the Company or a Subsidiary in respect of such calendar year, as
required to be reported to the Internal Revenue Service (“IRS”) on IRS Form W-2 for such calendar year. 
 2.7    “Eligible Employee” shall mean only those persons who on an Offering Date (a) are Employees and (b) are not deemed for purposes of Section 423(b)(3) of the Code to own stock
possessing 5% or more of the total combined voting power or value of all classes of stock of the Company or a Subsidiary. 
 2.8    “Employees” shall mean all persons employed by the Company or any Subsidiary, within the meaning of Section 423(b)(1) of the Code, excluding persons (a) employed less than one
year, or (b) whose customary employment is 20 hours or less per week or for not more than five months per year. 
 2.9    “Exercise Date” shall mean the final day of each Offering Period. 
 2.10    “Fair Market Value” on a particular day means the last sale price regular way on such day or if such day is not a business day on the preceding business day, on the principal national
securities exchange on which the Common Stock is listed or admitted to trading as reported by such exchange, or if the Common Stock is not listed or admitted to trading on any national securities exchange, in the over-the-counter market on such day,
as reported by the Wall Street Journal or such other source that the Committee deems reliable (the “OTC reporting person”), or if there are no such prices reported on such exchange or by the OTC reporting person on such day, the average of
the closing high bid and low asking price of the Common Stock as reported by such exchange or the OTC reporting person, and if there be none, then as furnished to the Committee by any New York Stock Exchange or NASD member selected from time to time
by the Committee for such purpose. If there is no bid or asked price reported on any such day, the market value shall be determined by the Committee in accordance with the regulations promulgated under Section 2031 of the Code, or by any other
appropriate method selected by the Committee. 

 2.11    “Offering” shall mean the offering of
shares of Common Stock to Participants pursuant to this Plan that occurs on each Offering Date. 
 2.12    “Offering Date” shall mean the first day of each Offering Period. 
 2.13    “Offering Period” shall mean the periods commencing January 1 and July 1 of each calendar year and ending, respectively, on June 30 and December 31 of the same calendar
year. The first Offering Period shall commence on July 1, 2005. 
 2.14    “Participant” shall mean an Eligible Employee who elects to participate in the Plan and gives notice to the Company of such election in accordance with Section 5 hereof. 

2.15    “Plan” shall mean the AEP Industries Inc. 2005 Employee Stock Purchase Plan as
hereafter, from time to time, amended. 
 2.16    “Purchase Price” shall mean the
cost of Common Stock acquired pursuant to the Plan as determined under Section 9 hereof. 
 2.17    “Rules” shall mean the rules for administering the Plan adopted pursuant to Section 19 hereof. 
 2.18    “Stock Purchase Account” shall mean the record of payments made by a Participant in accordance with Section 6 hereof which is required to be
maintained in accordance with Section 7 hereof. 
 2.19    “Subsidiary” shall
mean any subsidiary corporation of the Company within the meaning of Section 424(f) of the Code. 
 3.    Shares Offered Pursuant To The Plan. The number of shares of Common Stock which may be offered under the Plan on or after July 1, 2005, shall not exceed 250,000, subject to adjustment in accordance with
Section 21 hereof. Such shares may be authorized but unissued shares, previously issued shares reacquired by the Company, or any combination thereof. 
 4.    Shares Purchased By Participants. Each Participant on an Offering Date shall be entitled to purchase from the Company, in the manner and on the terms herein provided,
whole shares of Common Stock at the Purchase Price set forth in Section 9 hereof with amounts withheld or paid pursuant to Section 6 hereof during the Offering Period commencing on such Offering Date and ending on the next succeeding
Exercise Date. Anything herein to the contrary notwithstanding, if any person entitled to purchase shares pursuant to any Offering hereunder would be deemed for purposes of Section 423(b)(3) of the Code to own stock (including any number of
shares which such person would be entitled to purchase hereunder and under any other such plan maintained by the Company or any Subsidiary) possessing 5% or more of the total combined voting power or value of all classes of stock of the Company, the
maximum number of shares which such person shall be entitled to purchase pursuant to this Plan shall be reduced to that number which, when added to the number of shares of stock of the Company which such person is so deemed to own (excluding any
number of shares which such person would be entitled to purchase hereunder), is one less than such 5%. 
 5.    Participation in Plan. Any Eligible Employee may become a Participant in the Plan by notifying the Company in writing of his intention to participate prior to the Offering Date on which an Offering commences
as the Committee may prescribe. Such notice shall be in the form prescribed by the Rules and shall be delivered by hand or mailed, postage prepaid, to the Secretary of the Company, or his designee. 
 6.    Method of Payment For Shares. 
 6.1    Payment for shares of Common Stock purchased hereunder shall be made by authorized payroll deductions from a
Participant’s Compensation pursuant to this Section. 

 6.2    In his written notice to the Company pursuant to Section 5
hereof, a Participant shall authorize a deduction, stated as a percentage (to tenths of a percent) from the payment of his Compensation during each Offering Period. The maximum deduction during any Offering Period shall not exceed 7.5% of
Compensation during that Offering Period or such lesser amount as the Committee may prescribe. The minimum deduction is 1.0% of Compensation. A Participant may not change the amount of his deductions during an Offering Period, but may change the
amount to be deducted for any subsequent Offering by filing notice thereof prior to the Offering Date on which such subsequent Offering commences in the manner provided in Section 5 hereof. 
 7.    Stock Purchase Accounts. A Stock Purchase Account shall be established and maintained in the name of each
Participant. Amounts deducted from a Participant’s Compensation pursuant to Section 6 hereof shall be credited to his Stock Purchase Account. The amounts deducted will be credited to the Participant under the Plan, but the Company will not
establish any actual separate account to hold such amounts. The Company may comingle the deducted amounts with its general assets which it uses for general corporate purposes. 
 8.    Interest. No interest shall accrue or be payable to any Participant with respect to any amounts credited to
his Stock Purchase Account. 
 9.    Purchase Price. The Purchase Price per share of the shares of
Common Stock sold to Participants hereunder for any Offering shall be the lesser of 85% of the Fair Market Value per share of Common Stock on (i) the Offering Date or (ii) the Exercise Date. 
 10.    Purchase of Shares. If as of any Exercise Date there is credited to the Stock Purchase Account of a
Participant an amount at least equal to the Purchase Price of one share of Common Stock, as determined in Section 9 hereof, for the Offering which expires on such Exercise Date, the Participant shall purchase from the Company at such Purchase
Price the largest number of whole shares of Common Stock which can be purchased with the amount credited to his Stock Purchase Account, provided, however, subject to adjustment as set forth in Section 21 hereof, the maximum number of shares
that may be purchased by any Participant in a given Offering Period shall be 5,000 shares of Common Stock. 
 11.    Expiration of Offering. As of each Exercise Date the amount credited to the Stock Purchase Account of each Participant in the Offering which expires on such Exercise Date shall be charged with the aggregate
Purchase Price of the shares of Common Stock purchased by the Participant on such Exercise Date. The remaining balance credited to his Stock Purchase Account shall be refunded to each Participant, except that a remaining balance in a
Participant’s Stock Purchase Account representing a fractional share will be credited to his Stock Purchase Account for the next succeeding Offering hereunder if the Participant has not otherwise withdrawn from the Plan in accordance with
Section 13 hereof or requested in writing prior to the Exercise Date that such fractional share amount be refunded to him. 
 12.    Issuance of Shares, Stock Certificate; Notice to Company Upon Disposition. 
 12.1    The shares of Common Stock purchased by a Participant on an Exercise Date shall, for all purposes, be deemed to have been sold at the close of business on such Exercise Date. Prior to that time the Participant
shall have none of the rights or privileges of a stockholder of the Company with respect to such shares. 
 12.2    As soon as practicable after each Exercise Date, the Company shall, in the Committee’s sole determination as set forth in the Stock Purchase Agreement, (A) issue and deliver a certificate for the number
of shares of Common Stock purchased by a Participant on such Exercise Date, which certificate shall be registered either in the Participant’s name or jointly in the names of the Participant and his spouse, with the right of survivorship, as the
Participant shall designate (or change at any time) in a written notice to the Company pursuant to Section 23 hereof or (B) issue and deposit shares of Common Stock directly into a brokerage account which the Company shall establish for
the Participant at a Company-designated brokerage firm, and the Company may utilize electronic or automated methods of share transfer. 
 12.3    The Participant shall be required to promptly notify the Company if such Participant, directly or indirectly, sells or otherwise disposes of any shares purchased in any Offering Period. 

 13.    Voluntary Withdrawal from Plan. A Participant may withdraw
from the Plan at any time by filing a timely notice of withdrawal in the manner provided in Section 23 hereof. Upon a Participant’s withdrawal, the entire amount credited to his Stock Purchase Account shall be refunded to him. Any
Participant who withdraws from the Plan may again become a Participant hereunder with respect to a future Offering Period by filing notice in accordance with Section 5 hereof. 
 14.    Involuntary Withdrawal from Plan. If a Participant ceases to be an Employee by reasons of clause
(b) of Section 2.8 hereof, the entire credit balance in his Stock Purchase Account as of the effective date on which he so ceased to be an Employee shall be used to purchase shares of Common Stock pursuant to Sections 9 and 10 hereof as of
the next Exercise Date and any remaining balance credited to his Stock Purchase Account shall be refunded to him. 
 15.    Termination of Employment. If a Participant ceases to be an Employee other than by reason of clause (b) of Section 2.8 hereof, the entire credit balance in his Stock Purchase Account shall be
refunded to him. If a Participant dies, the entire credit balance in his Stock Purchase Account shall be paid over to his estate. 
 16.    Procedure if Insufficient Shares Available. In the event that on any Exercise Date the aggregate funds available for the purchase of shares of Common Stock pursuant to Section 9 hereof would purchase a
number of shares in excess of the number of shares then available for purchase under the Plan, the Committee shall proportionately reduce the number of shares which would otherwise be purchased by each Participant on such Exercise Date in order to
eliminate such excess, the Plan shall automatically terminate immediately after such Exercise Date and any remaining balance credited to the Stock Purchase Account of a Participant shall be refunded to such Participant. 
 17.    Limitation on Right to Purchase. Anything herein to the contrary notwithstanding, if at any time when any
person is entitled to complete the purchase of any shares pursuant to this Plan, taking into account such person’s rights, if any, to purchase stock under all other stock purchase plans of the Company or any Subsidiary, the result would be that
during the then current calendar year such person would have first become entitled to purchase under this Plan and all such other plans a number of shares of stock which would exceed the maximum number of shares permitted by the provisions of
Section 423(b)(8) of the Code, then the number of shares which such person shall be entitled to purchase pursuant to this Plan shall be reduced by the number which is one more than the number of shares which represents the excess. 

18.    Rights Not Transferable. Rights to purchase shares under this Plan are exercisable only by the
Participant during his lifetime and are not transferable. If a Participant attempts to transfer his rights to purchase shares under the Plan, he shall be deemed to have requested withdrawal from the Plan and the provisions of Section 13 hereof
shall apply with respect to such Participant. 
 19.    Administration of the Plan. Subject to the
general control of, and superseding action by, the Board of Directors, the Committee shall have full power to administer the Plan, including the authority and responsibility specifically provided in this Plan and any additional duty, responsibility
and authority delegated to the Committee by the Board, which may include any of the functions assigned to the Board in this Plan. The Committee shall adopt Rules not inconsistent with the provisions of the Plan for its administration, including the
form of all notices required hereunder. The Committee’s interpretation and construction of the Plan and Rules shall, subject as aforesaid, be final and conclusive. 
 20.    Amendment of the Plan. The Board of Directors may at any time, or from time to time, alter or amend the Plan in any respect, except that, without approval of the
stockholders, no amendment may (i) change the number of shares reserved under the Plan other than as provided in Section 21 hereof, (ii) reduce the Purchase Price per share as determined under Section 9 hereof other than as
provided in Section 21 hereof, (iii) permit any person who is not an Employee to participate in the Plan, or (iv) make any other changes for which stockholder approval is required pursuant to legal requirements relating to the
administration of an employee stock purchase plan under applicable U.S. state corporate laws, U.S. federal and applicable state securities laws, the Code, or any stock exchange rules or regulations, as such laws, rules, regulations and requirements
shall be in place from time to time. 

 21.    Recapitalization and Corporate Reorganization. 

21.1    The aggregate number of shares of Common Stock reserved for purchase under the Plan as provided in
Section 3 hereof, the maximum number of shares which may be purchased by a Participant in an Offering Period as provided in Section 10 hereof, and the Purchase Price per share as provided in Section 9 hereof shall be appropriately
adjusted to reflect any increase or decrease in the number of issued shares of Common Stock resulting from a subdivision or consolidation of shares or other capital adjustment, or the payment of a stock dividend, or other increase or decrease in
such shares effected without receipt of consideration by the Company. The Board shall take any further actions which, in the exercise of its discretion, may be necessary or appropriate under the circumstances. The Board’s determinations under
this Section 21 shall be conclusive and binding on all parties. 
 21.2    Subject to any required
action by the stockholders, if the Company shall be the surviving or resulting corporation in any merger or consolidation, any Offering hereunder shall pertain to and apply to the shares of stock of the Company, but a dissolution or liquidation of
the Company or a merger or consolidation in which the Company is not the surviving or the resulting corporation, shall cause the Plan and any Offering hereunder to terminate and the entire amount credited to the Stock Purchase Account of each
Participant hereunder shall be paid to such Participant. 
 22.    Expiration and Termination of the
Plan. The Plan shall continue in effect through June 30, 2015, unless terminated prior thereto pursuant to Section 21 hereof, provided that the Board of Directors shall have the right to terminate the Plan at any time. In the event of
the expiration of the Plan or its termination pursuant to Sections 21 or 22 hereof, the entire amount credited to the Stock Purchase Account of each Participant hereunder shall be refunded to the Participant. 
 23.    Notice. Any notice which a Participant files pursuant to this Plan shall be in the appropriate form
prescribed by the Rules or, if no provision is made in such Rules for the particular kind of notice in question, such notice shall be in writing and shall be delivered by hand or mailed, postage prepaid, to the Secretary of the Company, or his
designee. 
 24.    Repurchase of Stock. The Company shall not be required to repurchase from any
Participant shares of Common Stock which he acquires under this Plan. 
 25.    Alternative Contribution
Methods. Anything herein to the contrary notwithstanding, in the event that authorized payroll deductions from Employees’ Compensation are not permitted by reason of the provisions of local law applicable to the Company or any Subsidiary,
the Committee shall adopt an appropriate alternative method pursuant to which affected Employees may make payment for shares of Common Stock purchased hereunder which would otherwise have been made pursuant to Section 6 hereof. Payments made
hereunder shall be deemed to have been made pursuant to Section 6 hereof.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}]]